Ignite Creation Date:
2024-05-05 @ 5:31 PM
Last Modification Date:
2024-10-26 @ 9:33 AM
Study NCT ID:
NCT00478361
Status:
COMPLETED
Last Update Posted:
2020-10-09
First Post:
2007-05-23
Brief Title:
Gemcitabine Paclitaxel Doxorubicin in Metastatic or Unresectable Bladder Cancer With Decreased Kidney Function
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Distal Urethral Cancer |
| Metastatic Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Proximal Urethral Cancer |
| Recurrent Bladder Cancer |
| Recurrent Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Recurrent Urethral Cancer |
| Regional Transitional Cell Cancer of the Renal Pelvis and Ureter |
| Stage III Bladder Cancer |
| Stage IV Bladder Cancer |
| Transitional Cell Carcinoma of the Bladder |
| Urethral Cancer Associated With Invasive Bladder Cancer |
Keywords: